This inventor holds 2 USPTO granted patents. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: The Innovative Contributions of Harald Thuering
Introduction
Harald Thuering, an esteemed inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of pharmaceutical research and development. With a focus on innovative assays and methods, Thuering holds two notable patents that reflect his expertise and creativity in the scientific community.
Latest Patents
The first of Harald Thuering's recent patents addresses the use of IRS-polypeptides for identifying pharmaceutically active compounds. This invention encompasses an assay designed to determine the ability of an enzyme, its functional fragments, or derivatives to modify the phosphorylation status of a biotinylated polypeptide. This innovation is crucial in advancing drug development and understanding enzyme activity.
His second patent introduces a high-throughput assay characterized by high sensitivity for measuring the activity of β-adrenergic receptor kinase and investigating the effects of test substances on such activity. This invention involves an amplified luminescent proximity homogenous assay, which is instrumental in the study of G-Protein-Coupled Receptors specific protein kinases.
Career Highlights
Harald Thuering is currently affiliated with Sanofi-Aventis Deutschland GmbH, where he leverages his expertise to further advancements in pharmaceutical research. His career has been marked by a commitment to developing innovative solutions that enhance the efficiency and effectiveness of drug discovery processes.
Collaborations
Throughout his career, Thuering has collaborated with notable colleagues, including Aimo Kannt and Antje Pommereau. These partnerships highlight the importance of teamwork in the scientific field, fostering an environment where ideas can flourish and lead to groundbreaking innovations.
Conclusion
Harald Thuering's contributions to the field of pharmaceuticals through his innovative patents have positioned him as a notable figure in the industry. His work, particularly in the development of assays for identifying active compounds and monitoring enzymatic activity, continues to influence the ongoing progression of drug discovery and development.